Saturday, 8 June 2019

Time to review the risk benefit ratio of using NSAID in pregnancy should we use in pregnancy associated with inflammatory bowel or chronic rheumatic diseases? Any adverse effect on growing foetus?


Time to review the risk benefit ratio  of using NSAID in pregnancy should we use in pregnancy associated with inflammatory bowel or chronic rheumatic diseases? Any adverse effect on growing foetus?

Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn.



Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed in pregnancy to treat fever, pain and inflammation. Indications for chronic use of these agents during pregnancy are inflammatory bowel or chronic rheumatic diseases. Since the seventies, NSAIDs have been used as effective tocolytic agents: indomethacin has been the reference drug, delaying delivery for at least 48 hours and up to 7-10 days. Additionally, self-medication with NSAIDs is practiced by pregnant women. NSAIDs given to pregnant women cross the placenta and may cause embryo-fetal and neonatal adverse effects, depending on the type of agent, the dose and duration of therapy, the period of gestation, and the time elapsed between maternal NSAID administration and delivery. These effects derive from the action mechanisms of NSAIDs (mainly inhibition of prostanoid activity) and from the physiological changes in drug pharmacokinetics occurring during pregnancy. Increased risks of miscarriage and malformations are associated with NSAID use in early pregnancy. Conversely, exposure to NSAIDs after 30 weeks' gestation is associated with an increased risk of premature closure of the fetal ductus arteriosus and oligohydramnios. Fetal and neonatal adverse effects affecting the brain, kidney, lung, skeleton, gastrointestinal tract and cardiovascular system have also been reported after prenatal exposure to NSAIDs. NSAIDs should be given in pregnancy only if the maternal benefits outweigh the potential fetal risks, at the lowest effective dose and for the shortest duration possible. This article discusses in detail the placental transfer and metabolism of NSAIDs, and the adverse impact of prenatal NSAID exposure on the offspring.
PMID: 22299823
NSAIDs: maternal and fetal considerations.

Nonsteroidal anti-inflammatory drugs (NSAIDs) gained popularity in the late 1970s. Inhibition of prostaglandin synthesis with indomethacin has been reported to be effective for prevention of labor and for treatment for symptomatic polyhydramnios. Concern about its possible constrictive effect on the fetal ductus arteriosus has limited its use in pregnancy. Maternal indomethacin therapy has also been associated with reduction in urine production in the fetus and with oligohydramnios. Obstetricians have discouraged pregnant women from taking analgesic doses of aspirin, mainly because of the availability of paracetamol (acetaminophen), which causes less gastric irritation, but also because of fear of maternal and fetal hemorrhage and of possible premature closure of the ductus. These fears largely derive from studies on patients taking large doses and from extrapolation from other NSAIDs. The likelihood that treatment with 60-75 mg/day of aspirin markedly reduces the incidence of preeclampsia and fetal intrauterine growth retardation makes it important to reexamine its use. This review describes the pharmacology and pharmacokinetics of aspirin with particular reference to pregnancy and considers teratogenesis, prolongation of pregnancy and labor, maternal bleeding, fetal and neonatal bleeding, possible effects on the ductus arteriosus and pulmonary circulation, and possible nonspecific effects on intelligence and breast feeding and acute toxicity in the neonate.

PMID: 1285865

Pattern of Self Prescribed Analgesic Use in a Rural Area of Delhi: Exploring the Potential Role of Internet.

Kochhar A1, Gupta T2.
Author information
Abstract
INTRODUCTION:
Analgesics are the most common self prescribed drugs. Although considered to be relatively safe, side effects are often seen when these drugs are used for prolonged period, in high doses or used where contraindicated. Majority of the consumers are not aware of the side effects. These days ample amount of information is available on web, it is important to explore its role in educating the population regarding the safe use of self prescribed analgesics.
AIM:
To explore pattern of analgesic use, to identify population at risk of developing side effects related to analgesic use, awareness of side effects and potential role of internet to bring awareness about safe use of self prescribed analgesic drugs in a rural area of Delhi.
MATERIALS AND METHODS:
A cross-sectional survey based study was done on 500 adults in the age group of 18-65 years of Madanpur Khadar area of South Delhi, India. Data collection was done by conducting visits to pharmacy shops from the people who were buying drugs without prescription and taking face to face interviews using a semi-structured questionnaire. Statistical analysis was performed using descriptive tests with Microsoft office excel 2007.
RESULTS:
Results of our study showed that among all the self prescribed analgesics paracetamol (57%) was used most frequently followed by aspirin and other NSAIDs. It was found that 9.6% of the consumers were having associated co-morbid illness, 11.4% were simultaneously taking other drugs and 15.2% were alcoholics. Majority (65.4%) of the buyers were not aware about any kind of side effects of the analgesics. Internet friendly consumers were found to be 44%. Ability to use internet and education level were found to be directly related (r=0.802).
CONCLUSION:
The pattern of analgesic consumption in the rural population of Delhi shows that a large number of consumers may be at risk of developing side effects of self prescribed analgesics. The awareness about the side effects is limited. A significant number of consumers are internet friendly. Hence, we recommend use of website/mobile apps as potential source of information in educating the population regarding the use of self prescribed analgesics.

Nonsteroidal anti-inflammatory drugs during pregnancy and the initiation of lactation.

Nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin, which are available as "over-the counter" medications in most countries, are widely used by both pregnant and lactating women. They are popular non-opioid analgesics for the treatment of pain after vaginal and operative delivery. In addition, NSAIDs are used for tocolysis in premature labor, and low-dose aspirin has a role in the prevention of preeclampsia and recurrent miscarriage in antiphospholipid syndrome. NSAIDs and aspirin may affect fertility and increase the risk of early pregnancy loss. In the second trimester their use is considered reasonably safe, but has been associated with fetal cryptorchism. In the third trimester, NSAIDs and aspirin are usually avoided because of significant fetal risks such as renal injury, oligohydramnios, constriction of the ductus arteriosus (with potential for persistent pulmonary hypertension in the newborn), necrotizing enterocolitis, and intracranial hemorrhage. Maternal administration or ingestion of most NSAIDs results in low infant exposure via breastmilk, such that both cyclooxygenase-1 and cyclooxygenase-2 inhibitors are generally considered safe, and preferable to aspirin, when breastfeeding.

PMID: 23558845

NSAID Use During Pregnancy Linked to Pulmonary Hypertension In Newborns
NSAID use during pregnancy increases the risk of pulmonary hypertension in newborns, according to a recently published study. Yet, women commonly use the drugs while they are pregnant despite labels that warn against doing so.
In a case-control study published in the March issue of Pediatrics, meconium was collected from 101newborn infants and analyzed for the presence of ibuprofen (e.g., Advil -- Whitehall Robbins), naproxen (e.g., Aleve -- Bayer), indomethacin (e.g., Indocin -- Merck), and aspirin. Results from 40 infants with persistent pulmonary hypertension of the newborn (PPHN), an often fatal complication, were compared with those of 61 randomly selected, healthy, full-term infants.
 Putting the Fetus at Risk
Overall, 49.5% of the meconium samples were positive for NSAIDs: 22.8% were positive for ibuprofen, 18.8% for naproxen,7.9% for indomethacin, and 43.6% for aspirin. PPHN was significantly associated with both the presence of at least one NSAID in the meconium and, in particular, the presence of aspirin,ibuprofen, or naproxen.
NSAIDs block the synthesis of prostaglandins and thromboxane, which are needed to keep open the ductus arterious, the blood vessel that shunts blood past the lungs in the fetus. When the vessel closes early, pulmonary hypertension results. Since NSAIDs cross the placenta easily and have a prolonged half-life in the fetus, they should be avoided during pregnancy, especially in the last trimester
Although other studies have suggested a link between NSAIDs and PPHN, this is the first time an association has been clearly demonstrated, according to co-author Enrique M. Ostrea Jr, MD, professor of pediatrics at Wayne State University and chief of pediatrics at Detroit's Hutzel Hospital.
In the February 3 edition of BMJ, European researchers reported a tentative connection between NSAID use and an increased risk of miscarriage. The odds ratios of women receiving an NSAID prescription in the last week before a miscarriage was 6.99; the odds ratio dropped to 2.69 when an NSAID prescription had been taken 7 to 9 weeks before miscarriage.

The authors of the Pediatrics study were surprised by the widespread use of the drugs. Use was grossly underreported as well, a finding confirmed by other researchers.
Women are thought to forget taking such common, everyday products and may not recognize their presence in multi-ingredient OTC medications. The widespread, easy availability of NSAIDs may also lull pregnant women into a false sense of safety.
The Pediatrics authors called for a reevaluation of the easy access pregnant women have to OTC NSAIDs as well as effective promotion of the dangers the drugs pose to the fetus.
Ostrea thinks the solution lies in stricter labeling, similar to what already exists on tobacco and alcohol products. Labeling should state explicitly that use could cause potentially fatal lung damage in infants, Ostrea said. "Similar statements on alcohol and cigarette labels have significantly reduced use during pregnancy."
He does not think it is necessary to place NSAIDs in a third, pharmacist-only drug class because all patients, not just pregnant women, use the products. Pharmacists should, however, warn pregnant women of the risks involved if they see them buying NSAIDs.


Refresh our knowledge on RPL (Recurrent pregnancy loss)



Refresh our knowledge on RPL (Recurrent pregnancy loss)
Recurrent pregnancy loss is disheartening to the couple and to the treating clinician. There has been a wide range of research from aetiology to management of recurrent pregnancy loss. It is one of the most debated topic among clinicians and academics. The ideal management is unanswered. This review is aimed to produce an evidence-based guidance on clinical management of recurrent miscarriage. The review is structured to be clinically relevant. We have searched electronic databases (PubMed and Embase) using different key words. We have combined the searches and arranged them with the hierarchy of evidences. We have critically appraised the evidence to produce a concise answer for clinical practice. We have graded the evidence from level I to V on which these recommendations are based.
KEYWORDS:
Aspirin; antiphospholipid syndrome; immunotherapy; low molecular weight heparin; recurrent miscarriage; recurrent pregnancy loss; unexplained
PMID:

Early recurrent miscarriage: Evaluation and management

OBJECTIVE:

To establish recommendations for early recurrent miscarriages (≥3 miscarriages before 14weeks of amenorrhea).

MATERIALS AND METHODS:

Literature review, establishing levels of evidence and recommendations for grades of clinical practice.

RESULTS:

Women evaluation includes the search for a diabetes (grade A), an antiphospholipid syndrome (APS) (grade A), a thyroid dysfunction (grade A), a hyperprolactinemia (grade B), a vitamin deficiency and a hyperhomocysteinemia (grade C), a uterine abnormality (grade C), an altered ovarian reserve (grade C), and a couple chromosome analysis (grade A). For unexplained early recurrent miscarriages, treatment includes folic acid and progesterone supplementation, and a reinsurance policy in the first quarter (grade C). It is recommended to prescribe the combination of aspirin and low-molecular-weight heparin when APS (grade A), glycemic control in diabetes (grade A), L-Thyroxine in case of hypothyroidism (grade A) or the presence of thyroid antibodies (grade B), bromocriptine if hyperprolactinemia (grade B), a substitution for vitamin deficiency or hyperhomocysteinemia (grade C), sectionning a uterine septum (grade C) and treating an uterine acquired abnormality (grade C).

CONCLUSION:

These recommendations should improve the management of couples faced with early recurrent miscarriages.
Early recurrent miscarriage: Evaluation and management].
[Article in French]
Gallot V1, Nedellec S2, Capmas P3, Legendre G4, Lejeune-Saada V5, Subtil D6, Nizard J7, Levêque J8, Deffieux X2, Hervé B9, Vialard F9.
Author information
Abstract
OBJECTIVE:
To establish recommendations for early recurrent miscarriages (≥3 miscarriages before 14weeks of amenorrhea).

MATERIALS AND METHODS:
Literature review, establishing levels of evidence and recommendations for grades of clinical practice.

RESULTS:
Women evaluation includes the search for a diabetes (grade A), an antiphospholipid syndrome (APS) (grade A), a thyroid dysfunction (grade A), a hyperprolactinemia (grade B), a vitamin deficiency and a hyperhomocysteinemia (grade C), a uterine abnormality (grade C), an altered ovarian reserve (grade C), and a couple chromosome analysis (grade A). For unexplained early recurrent miscarriages, treatment includes folic acid and progesterone supplementation, and a reinsurance policy in the first quarter (grade C). It is recommended to prescribe the combination of aspirin and low-molecular-weight heparin when APS (grade A), glycemic control in diabetes (grade A), L-Thyroxine in case of hypothyroidism (grade A) or the presence of thyroid antibodies (grade B), bromocriptine if hyperprolactinemia (grade B), a substitution for vitamin deficiency or hyperhomocysteinemia (grade C), sectionning a uterine septum (grade C) and treating an uterine acquired abnormality (grade C).

CONCLUSION:
These recommendations should improve the management of couples faced with early recurrent miscarriages.

Current concepts and new trends in the diagnosis and management of recurrent miscarriage

Pregnancy is a proinflammatory and hypercoagulable state. Miscarriage concerns approximately 15% of pregnancies. Recurrent miscarriage is a rather rare condition with an estimated incidence of 1% to 3%. However, despite years of investigation, the etiology is not established in up to 50% of cases. A multidisciplinary approach in the evaluation of miscarriage is essential to understand the cause and risk of recurrence. Although genetic factors are the major cause of spontaneous miscarriages, their relationship with recurrent miscarriage is less frequent. Recently, many kinds of genetic polymorphisms have also been found to be associated. Endocrine disorders such as poorly controlled diabetes, polycystic ovary syndrome, and hypothyroidism are linked with recurrent miscarriage. The relationship between recurrent miscarriage and subclinical thyroid disorders and thyroid autoimmunity is disputed, especially in early miscarriages. Uterine malformations should be considered as a cause of recurrent miscarriage. Although autoimmune-based recurrent miscarriage has been described, mainly antiphospholipid antibodies, the role of alloimmune mechanisms remains poorly understood. The influence of congenital thrombophilia is controversial. Antiphospholipid syndrome or antiphospholipid antibody-related recurrent miscarriage, and some endocrinologic disorders, have a specific and effective treatment. Still, the effectiveness of some common treatments needs to be demonstrated.

Association of parental methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in couples with unexplained recurrent pregnancy loss

Abstract
OBJECTIVE:
The aim of this study was to identify the association of parental MTHFR C677T gene polymorphism in couples with and without RPL history.

RESULTS:
During the study, 21.4% (15/70) of Ala222Val polymorphism was observed among RPL couples while no polymorphism was seen among normal, healthy couples. Our study did not find any association between MTHFR C677T polymorphism and gender (p > 0.05), gestational period (p > 0.05), geographical region (p > 0.05) and menstrual history (p > 0.05). However, significant association was seen between MTHFR C677T polymorphism and number of losses (p < 0.05), concluding that the risk of the polymorphism increased with the increase in number of losses. Significant variation in the MTHFR C677T genotype with number of losses among RPL couples were seen but not with other study variables.

EIF5A1 promotes trophoblast migration and invasion via ARAF-mediated activation of the integrin/ERK signaling pathway.

Trophoblast dysfunction is one mechanism implicated in the etiology of recurrent miscarriage (RM). Regulation of trophoblast function, however, is complex and the mechanisms contributing to dysregulation remain to be elucidated. Herein, we found EIF5A1 expression levels to be significantly decreased in cytotrophoblasts in RM villous tissues compared with healthy controls. Using the HTR-8/SVneo cell line as a model system, we found that overexpression of EIF5A1 promotes trophoblast proliferation, migration and invasion in vitro. Knockdown of EIF5A1 or inhibiting its hypusination with N1-guanyl-1,7-diaminoheptane (GC7) suppresses these activities. Similarly, mutating EIF5A1 to EIF5A1K50A to prevent hypusination abolishes its effects on proliferation, migration and invasion. Furthermore, upregulation of EIF5A1 increases the outgrowth of trophoblasts in a villous explant culture model, whereas knockdown has the opposite effect. Suppression of EIF5A1 hypusination also inhibits the outgrowth of trophoblasts in explants. Mechanistically, ARAF mediates the regulation of trophoblast migration and invasion by EIF5A1. Hypusinated EIF5A1 regulates the integrin/ERK signaling pathway via controlling the translation of ARAF. ARAF level is also downregulated in trophoblasts of RM villous tissues and expression of ARAF is positively correlated with EIF5A1. Together, our results suggest that EIF5A1 may be a regulator of trophoblast function at the maternal-fetal interface and low levels of EIF5A1 and ARAF may be associated with RM.

A national survey on public perceptions of miscarriage

Author information

1
Program for Early and Recurrent Pregnancy Loss (PEARL), Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, the Department of Obstetrics & Gynecology and Women's Health, Mount Sinai Medical Center, the Department of Obstetrics and Gynecology, Montefiore Medical Center, and the Department of Obstetrics & Gynecology, New York University Langone Medical Center, New York, New York; the Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, and the Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and the University of Sydney Medical School, Sydney, Australia.

Abstract

OBJECTIVE:

To assess attitudes and perceptions of U.S. survey respondents regarding prevalence, causes, and emotional effects of miscarriage.

METHODS:

We used a questionnaire consisting of 33 questions administered in January of 2013 to men and women aged 18-69 years across the United States.

RESULTS:

Participants from 49 states completed the questionnaire: 45% male and 55% female (N=1,084). Fifteen percent reported they or their partner experienced at least one miscarriage. Fifty-five percent of respondents believed that miscarriage occurred in 5% or less of all pregnancies. Commonly believed causes of miscarriage included a stressful event (76%), lifting a heavy object (64%), previous use of an intrauterine device (28%), or oral contraceptives (22%). Of those who had a miscarriage, 37% felt they had lost a child, 47% felt guilty, 41% reported feeling that they had done something wrong, 41% felt alone, and 28% felt ashamed. Nineteen percent fewer people felt they had done something wrong when a cause for the miscarriage was found. Seventy-eight percent of all participants reported wanting to know the cause of their miscarriage, even if no intervention could have prevented it from occurring. Disclosures of miscarriages by public figures assuaged feelings of isolation for 28% of respondents. Level of education and gender had a significant effect on perceptions and understanding of miscarriage.

CONCLUSION:

Respondents to our survey erroneously believed that miscarriage is a rare complication of pregnancy, with the majority believing that it occurred in 5% or less of all pregnancies. There were also widespread misconceptions about causes of miscarriage. Those who had experienced a miscarriage frequently felt guilty, isolated, and alone. Identifying a potential cause of the miscarriage may have an effect on patients' psychological and emotional responses.

LEVEL OF EVIDENCE:

II.


A gentle reminder for contraceptive providers, Pl counsel about the duration of Pill intake after measuring BP & F/H/O VTE, MI etc. Let us quickly recapitulate why very occasionally an Indian woman develop venous thrombosis when she is on OCP (COC) specially if she is on high dose for long yrs without the knowledge of the provider. Indian women are relatively immune to VTE. Blessings of God!!


Oestrogens & VTE:-- Estrogen cause slight increase in fibrinogen and by that promotes slightly  Of the contraceptive steroids we should remember that it is the estrogen which causes hypercoagulable state and is primarily attributed for DVT and allied thrombosis during OCP intake. The risk of VTE is directly related to dose of E but the OCP induced risk of VTE IN PREGNANCY IS LOWER THAN THE RSIK ASSOCIATED WIRH EVEN LOW-DOSE COC.
Inherited Thrombophilia:-  But as we know in some countries factor Leiden mutation, Protein-C /S synthesis disorders (DEFICIENT PRODUCTION) or prothrombin mutation disorders are to the extent of 0.5 to 5% of general population in those countries. In such countries it will be prudent to screen women who candidates for inherited thrombophilias and refrain from prescribing OCP if screen +ve or family is +ve/ or she herself has already suffered from DVT in the recent past.. This is not true for our country.
Acquired APC resistance:-  APC resistance :- APC naturally down regulates the thrombin formation. APC therefore is a naturally occurring the prevalence of DVT in acquired APC resistance is 6/10,000 women in reproductive years. Who are not.OCP? But if one uses OVP then the prevalence goes up to Increased APC resistance can invite thrombosis.
PCOS & Venous thrombosis:- using Thrombosis can occur at varying sites including legs, thigh veins, lungs,

What are the sonological features of dwindling ovarian function/ reserve/ Stock In USG - what the USG image whisper us ? What an expert sonologist should look for we should look for? What mind doesn't know eyes cannot see!!!


USG will reveal followings. My dear sonologist please keep an eye and be vigil if any of the following findings are imagable in a women who has cycle was cancelled due to non development of follicle even with high dose of gonadotrophins - a gentle reminder
1) Heterogeneous myometrial area.
2) Globular asymmetric uterus.
3) Irregular cystic spaces.
4) Myometrial linear striae.
5) Poorly defined / demarcation of endometrial – myometrial junction.
6) Myometrial anterior- posterior wall asymmetry. Usually the post wall is thicker than the ant wall,
7)  Both the walls of myometrium may be thickened say anterior and posterior wall.
8) Increased or decreased echogenecity
Most of us use only USG for diagnosis confirmation as a cost savings approach while others have used all two parameters for diagnosis of adenomyosis like USG & MRI. This is truer when one considers for ART. Regarding endoscopic diagnosis the diag remains uncertain though hysteroscopy is more helpful in diagnosing than laparoscopy. In fact in fair number of cases the laparoscopy may be negative inspite of moderate to severe adenomyosis.

Friday, 7 June 2019

What is new in our knowledge on Physiology of Ovarian Reserve and Endocrine Function


What is new in  our knowledge on Physiology of Ovarian Reserve and Endocrine Function
Q.1. Is there any  recent change in aassesing   ovarian reserve which was so long  popular for last 3 decades like AMH & AFC:  Ans:You will  be surprised that many scientists have recently questioned the validity of AMH & AFC  imp assign   follicular stock ??
Q. 2. What was known to us??  :
Ans; Ovary contains a stock of follicles number of which gradually declines as age advances by a process of physiological apoptosis. Physiological atresia starts from intrauterine life the process of atresia continues through childhoodà puberty-à  adolescence à child bearing age till the stock is exhausted by the time when woman reaches menopause. We also know that from several millions of follicles appearing in intrauterine life the number is reduced to two millions at birth and 3,00,000 at puberty.

Q.3 . As she enters in reproductive life??
Ans:What happens in each menst cycle?? Ans:-During reproductive years with each menstrual cycle some 30 to 40 follicles are wasted.

Q. 5:-Which Follicles undergo  apoptosis first??
 Ans:-It should be noted that better quality follicles’ are exhausted in the first half of reproductive years followed by relatively interior quality follicles.

Q. 6 . Leave me alone: I am a Lady? Don’t you know manners?? Haven’t attend classes of Dr Pal (how gentle he is to me  !!)  For havens sake please don’t disturb me.  I shall communicate to my body guard Prof Pal, if you drill me or do unnecessary stripping of my cyst  wall which are too small based on USG ?? Prof Pal then, will sent to you Jail if U unnecessary touch me,
.Ans:- Dr. Pal has told me what is bad touch ( excess drilling too many holes, high current ., deep holes –the law of 4 forgotten )  & what is good touch(big chocolate cyst) !! You must know that one President gently slapped Queen at Brimming ham Palace but that was a good humorous touch.
Ans:-Therefore no unnecessary ovarian surgery please: During this long journey from puberty to menopause any trauma or insult to the ovary may lead to qualitative and quantitative loss of follicles reducing ovarian reserve prematurely

Q.7:-What was the parameter of Ov reserve so far?? What about FSH on day 3 of spont cycles ?? 
Ans:- FSH does not indicate the quality of oocytes available.. One clinically useful indicator was to predict ovarian reserve is to measure the level of baseline follicle – stimulating hormone. Gradual rise of baseline FSH in consecutive cycles indicates diminishing ovarian reserve. Now scientist has concluded that FSH is a quantitative predictor of oocytes level of borderline elevated. FSH does not indicate the quality of oocytes available. From that point of view patient’s age and assessment of AMH are better qualitative predictors of ovarian reserve than baseline FSH.

Q.8. Is this hold good(Basal FSH)  in cases of genital Kochs induced affection of Ovary or T O mass ?? 
Ans:-As genital tuberculosis affects women of younger age better quality eggs are still available although ovarian reserve may be borderline. This fact provides a favorable scope for treating infertility by ART for women with genital tuberculosis. In genital Kochs there has been shown that demonstrates that though numbers of eggs are less quality of eggs is better because of relatively younger age of the patient affected with genital tuberculosis.
Q . 9. So FSH gone, which parameter of Ov reserve  next to consider ? Which  test will be the best predictor  of Ov reserve?? 
Ans:-A better qualitative predictor for ovarian reserve namely anti mullerian hormone has recently been identified. AMH is synthesized and released by granulosa cells of the follicle. Unlike other biomarkers for ovarian reserve like FSH inhibin or E2 estimation of AMH can be done on any day of menstrual cycle. This is because levels of serum FSH, E2 and inhibin B depend on individual feedback mechanism whereas production of AMH depends on health and integrity of granulosa cells and is not dependent on feedback mechanism.
Q.10:-Physiology of ovarian endocrine function : Ans:-What is our expectation , being under gonadotropin control ovaries  should be able to respond to appropriate  levels of gonadotropin and in response should be able to generate optimum amounts of ovarian  steroids namely oestrogen  and progesterone
Q. 11. What are the 33 Autocrine factors which are continuously governing the action of  FSH in the Granulosa  cells & theca cells and possibly on oolemma as well?? What controls –Intracellular signaling in ovarian cortex?? ?? ?? NDA?? UPA –Govt of many political parties!!  What is not known by NASA about the universe?? Who is Megnadh -who fights/ helps somebody himself  hiding  behind the cloud ? Parde pichhee kaea hai??
Ans:-to Q. 11 :-In  addition intraovarian peptides play important roles in regulating gonadotropic consist of autocrines  and paracrine. At least 33 putative Autocrine – paracrine regulators for follicular growth have been identified. They play a major role in follicular growth and atresia. The important members of Autocrine paracrine family consist of inhibin Activin insulin like growth factor vascular endothelial growth factor transforming growth factor alpha etc. They play important role in modulating gonadotropic effects on ovarian function and ovulation. These cordinate  ovarian endocrine functions are disrupted either directly through toxins produced by NTB or indirectly by adverse immune modulatory  change in intra follicular  environment . The consequences may be gonadotropin response deficiency anovulation endometrial hyperplasia luteal phase defect etc.
Q.12: Genital Kochs ?? How is the Ovarian  function affected  in genital tuberculosis ?? Kochs may  be adversely affected in following ways
a.  Morphological involvement of the ovaries: Ovaries are involved in 20 to 30% cases of genital tuberculosis . The degree of morphological involvement depends on the severity  and stage of the disease. There may be either tubercles on the ovary or adhesion caseation tubo ovarian cyst or mass formation. Rarely the ovaries may be completely destroyed by the disease. These types of tubercular ovarian affection may lead to both follicular stock depletion and endocrine disruption.
b.  Tubercular hydrosalpinx: TB hydrosalpinges may interfere with ovarian function either directly or indirectly. Fallopian tubes are involved in almost all women with genital tuberculosis involvement is usually bilateral. Tubercular hydrosalpinx is not uncommon in India. Other causes of tubal dilation include pelvic inflammatory disease adhesion and obstruction due to any cause. Scientists  have observed tubal dilatation with or without obstruction in 46%  of their patients with genital tuberculosis . Incidence  of tubo ovarian  mass has been reported to be 15.3%
Q.13:-Then?? Will full course of ATD I can’t become mother –Why??  Ans:-a possible link between LGTB and endometrial receptivity one of the key factors determining implantation which has not been studied so far we therefore aimed to evaluate  the various biochemical and morphological markers of endometrial receptivity  during implantation window in endometrial tissue of women with LGTB . The biochemical markers examined in th study were  the endometrial adhesion  molecules mucin a and an interleukin – 6 class cytokine leukemia inhibitor factor
Q. 14 “: TB what else is now known?? A significant decrease in a vB3 integrin . LIF, E cadherin, MECA- 79 and MUC-1 expression was observed in women with LGTB as compared to controls.
Q. 15 : What is Bologna criteria 2011 ?? Why that was frames?? I am sinking am drowning!! Please tell my father for my marriage .I am already 34 yrs!!! Ans: Over the past few decades  DOR / POR  has emerged as a challenge. The incidence in a population undergoing assisted reproduction treatment is estimated to be 9-24% . Measures have been taken to identity  such patients at risk or during treatment  for appropriate management  Bologna criteria 2011 is one such crucial step taken towards the introduction of a uniform definition of POR to guide the management and intervention strategies. It states that presence of at last two of the following three features are required for the diagnosis of POR:
1.  Advanced maternal age ( > 40 years ) or other risk factors
2.  Previous POR ( < 3 oocytes with conventional stimulation protocol )
3.  An abnormal Ovarian  Reserve Test (AFC 5-7 follicles or AMH 0.5 -1.1 ng/ml )
Q. Q. 16:- : New defn of por responders??  Ans:-Two episodes of POR after maximal stimulation categories  patient as poor responder in absence of advanced maternal age or abnormal  ovarian reserve test. Poor response  can be expected from patients with age> 40 years and abnormal  ORP. Then starts the quest for oocytes laying out plans and hoping for a good response.
. Q. 17 : Then we,  who are poor responders , have no hope to become biological mother ??  Ans: No. Not at all. Don’t lose your hope.  I don’t mean that. Hope is always there because Dr Pal is still typing personally at the age of 77 yrs, Then why I can’t produce my own good quality fertilizable egg at 39 yrs  with no post fertilization developmental errors ? !!  Ans: What are the steps so long adopted for so called poor responders??
Ans :: Various strategies have been tried so far  Modification : 1) gonadotropin dose adjustments
Modification : 2)  use of antagonist Modification : 3 Use of cofollitropin alfa, Modification 4:  Estradiol in luteal  phase. Modification :5:Addition of Growth hormone. Modification : 6 :Another such novel approach  is the use of Androgel.
Modification :  7 :: Will DHEA work?? How much money is spent per day for DHEA by couple?? What other modifications and deviation from Sc?? Ans:  Pretreatment with androgen has been a hot topic for  debate for many years. Androgen  acts primarily during FSH dependent  early folliculogenesis. Androgens act on granulose cells in early follicle  maturation and increases the sensitivity of the follicles to FSH via cANP mediated pathway. Androgen  receptor protein then decreased with advancing follicular maturation. Thus androgens and FSH work synergistically . A positive correlation has been observed between serum testosterone concentration and number of oocytes retrieved and the amount of FSH required.
Modification: 8: Other modalities of androgen administration??  Ans:-Various modes of testosterone administration are known  like DHEA, 1) testosterone patches and 2)  testosterone gel or androgel. Although DHEA has already found its way into the practice use of Androgel seems to be the most promising due to acceptable safety profile and better convenience. Androgel 1% gel contains 50 mg  testosterone which is biologically similar to testosterone which is biologically similar to testosterone secreted by human body.

Modification: 9 :Information on drug and its usage: Each  5 gm gel contains 50 mg of testosterone. So the dosage is a quarter of a gel which makes approximately 12.5  mg testosterone.
Modification: 10 :: How to use :  Androgel is to be used prior to ovarian  stimulation. It has been used in studies for a variable time period of 4-6 weeks. The feasible and systematic way to use it would be from Day 6 of previous cycle to Day 2 of stimulated menstrual cycle.
Modification: 11 :: How to apply : Step  1:. The gel should be applied preferably on inner upper arm or on shoulder or abdomen over a dry and clean area with intact skin. Step  :.  2. Take full gel in a syringe, apply  and discard the remaining gel. Step   3. Apply at night before bedtime Step  4. Leave it to dry for 3-5 minutes .5.Cover with clothing 6. Wash hands thoroughly Step  7. Nobody should come in contact with  the area  the gel has been applied to . Take bath after intimate contact.
Modification: 13: I don’t like be a male!! I am a woman. I am proud of my woman hood though I am still unable to reproduce. That is one aspect but believe me I am caring to my hubby and other family members.  .Then doc why you are prescribing male hormones to me? Do U like to change me as transgender-which I don’t like!!  Ans:-Special warning from Dr Pal about Safety profile of androgen ?  : Apart from possible local skin reaction such as irritation and dryness at the site of application not much of side effects have been observed  with such small dose used for short period of time.
Take home message from Dr Pal : :
Various studies have shown that use of Androgel in poor responders may result  in the increase in the number of mature  eggs, good quality embryos and better implantation rates but a randomized controlled trial is much needed to put this into practice. Few other studies state that although there is a definite increase in the number  of follicles  retrieved but the quality remains the same. This  goes  in consensus with the fact  that in condition such as PCOS  although there is hyperandrogenism and more number of follicles may be retrieved but quality is inferior. This is the point where the data falls short. With that said being said this simple approach has shown promising results and has entered the vernacular as a viable option to treat poor responders.

 Q.1. How we can reasonably confirm /diagnose Adenomyosis? Ans: -We know that subjective symptoms of adenomyosis are like endometriosis e, g. dysmenorrhea subfertility, pelvic pain and menometrorrhagia, but for confirmation there are basically two modalities which help us to confirm the clinical diagnosis of adenomyosis. Such are 1) MRI 2) USG.
Q2: what are the sonological features? In USG we should look for:-
1) Heterogeneous myometrial area.
2) Globular asymmetric uterus.
3) Irregular cystic spaces.
4) Myometrial linear striae.
5) Poorly defined / demarcation of endometrial – myometrial junction.
6) Myometrial anterior- posterior wall asymmetry. Usually the post wall is thicker than the ant wall,
7)  Both the walls of myometrium may be thickened say anterior and posterior wall.
8) Increased or decreased echogenecity
Most of us use only USG for diagnosis confirmation as a cost savings approach while others have used all two parameters for diagnosis of adenomyosis like USG & MRI. This is truer when one considers for ART. Regarding endoscopic diagnosis the diag remains uncertain though hysteroscopy is more helpful in diagnosing than laparoscopy. In fact in fair number of cases the laparoscopy may be negative inspite of moderate to severe adenomyosis.
Q.3:-What is meant by Junctional Zone & what is the role of JZ in the etiogenesis of adenomyosis. , The area of endomyometrial junction is known as junctional zone. Junctional Zone consists of three layers as detailed below:
a. Innermost myometrial layer
B. and the sub vascular layer above the endometrial cavity – also known as archi myometrium
c. Including basal endometrial layer
We know that the normal thickness of junctional zone is 7-8 mm. In adenomyosis the junctional zone thickness increases to > 12mm.

Q.4: Why & how adenomyosis develops? In case of adenomyosis this Jan zone play a vital part and in most of the cases the disease initiates with the invagination of JZ into myometrium due to various causes of which abnormal uterine peristalsis is mostly attributed.
Why abnormal peristalsis causing high intra uterine pressure??   The process of invagination of this JZ is thought to be suing either to a) abnormal peristaltic function or wave of peristalsis originating in this JZ or local structural abnormalities in the myometrial tissue. This structural abnormality may be congenital or acquired. These two factors are the chief causes of genesis of adenomyosis usually favour development of adenomyotic uterus. Besides c) abnormal hormonal and d) immunological conditions also have a commanding role to play in the normal functions of JZ and if any one goes wild then this increased pressure induced by uterine peristalsis may cause invagination of endometrium.
We know that the normal thickness of junctional zone is 7-8 mm. In adenomyosis the junctional zone thickness increases to > 12mm.

Q.5:-How adenomyosis cause subfertility or enhances spont miscarriage rate?
Ans:-Impediments to conception is brought about by A) increased uterine peristalsis, as mentioned earlier, which is partly governed by junctional zone. In cases of adenomyosis there is primary abnormality in junctional zone thickness à which leads to uterine dysperistalsis and therefore B) impairment of sperm transport...  In addition in adenomyosis there is also C) increased colonization by macrophages’) Secretory products of these macrophages have adverse impact on oocyte quality fertilization and implantation. These noxious products released  by macrophages trickles down to F tubeàthen via fimbrial end to the surface of ovary and it is believed that the said noxious agents / toxins liberated by endometrial macrophages is brought about via utero ovarian countercurrent systemà impedes oocyte dev environemetyt.
Q 6: What is Junctional Zone? Junctional Zone consists of three different components:-
a. On the outermost part is “innermost myometrial layer”.
B. In the middle part is “sub vascular layer deep to but adjoining the endometrial cavity – also known as archi myometrium
C. and most inside close to uterine cavity is the “basal endometrial layer”’
We know that the normal thickness of junctional zone is 7-8 mm. But in adenomyosis the junctional zone thickness increases to > 12mm.
Q.7. what is meant by normal uterine peristalsis? How such peristlasis may go wild and may become an etiologic factor of genesis of adenomyosis? Ans: Increased peristalsis which creates increased intra uterine pressure – leading to invagination of basal endometrium into the myometrium --Uterine myometrium has a regular pattern of peristalsis regulated by endocrine and paracrine stimuli. Junctional zone thickness causes increased peristalsis which creates increased intra uterine pressure – leading to invagination of basal endometrium into the myometrium. Invagination is more commonly found on posterior wall of uterus. Invagination is also facilitated by weakness of smooth muscle tissue of uterus .Weakness may be due to high estrogen  concentration in the local area or impaired immune related growth factor.
Q8. What are the other pelvic pathologies which may be associated with adenomyosis? Apart from pelvic endometriosis adenomyosis may be associated with other pelvic pathological conditions like 1) leiomyomas 2) endometrial hyperplasia 3) endometrial polyp 4) atypical endometrial hyperplasia and rarely 5) adeno carcinoma. However presence adeno myoma or adenomyosis has no adverse effect on the prognosis of endometrial carcinoma.
Q.9. How we can confirm the clinical diagnosis of adenomyosis? There are two modalities which help us to confirm the diag of adenomyosis? Such are 1) MRI 2) USG.: In USG we should look for:-
1) Heterogeneous myometrial area.
2) Globular asymmetric uterus.
3) Irregular cystic spaces.
4) Myometrial linear striae.
5) Poor definition of endomyometrial   junction.
6) Myometrial anterior- posterior wall asymmetry.
7) Thickening of anterior and posterior wall.
8) Increased or decreased echogenecity
Most of us use only USG for cost savings while others have used all both parameters for diagnosis of adenomyosis .Hysteroscopy is more helpful in diagnosing than laparoscopy...
Q.10: How best to treat adenomyosis?? A) If Uterus exceeds 10 cm –presenting with menorrhagia and dysmenorrhea hysterectomy with preservation of ovaries for future surrogacy is considered to be the rational /effective treatment. Therefore Conservative surgery +- agonist (GnRH agonist) or one can use Danazol loaded intra uterine device. In rest cases where the uterine length is less than 10 Cm then following 7 options are available. Like 1)GnRH a for six months 2) Wedge biopsy 3) Uterine artery embolization 4) High intensity focused ultrasound
5) Ultra long GnRH followed by IVF vs. conventional Ivf. 6)
Combination of conservative surgery plus GnRH-a
7) LNG or danazol loaded IUs 8) Conservative surgery alone .9) High intensity focused ultrasound & Uterine artery embolization 10) Laparoscopic partial resection of uterus with uterine artery occlusion.


Q.11: What will the Obstetric Outcome in adenomyosis? Ans:-The obstetric outcome in an adenomyotic uterus include 1) Increased risk of preterm premature rupture of membranes 2)
Uterine rupture or perforation -29 cases from 1904 to 1984 plus an ectopic pregnancy in adenomyotic area were reported by Aziz et al 3) Rapid enlargement of adenomyotic uterus in pregnancy conceived after controlled ovarian stimulation has been reported. In fact, ART may lead to red degeneration during pregnancy and 4) PPH during and following delivery.
Q. 12: If you like to moderate a session in a CME on adenomyosis / endometriosis then may put such 11 questions as Chair person. I firmly believe the Conference Hall will be vacant and all the delegates including the panelists will be assembling there.

















































 Be that as it may what are those tips which will cause annoyance to audience??  :
Take home message 1:-Diag modality: The best method??  Apart from many diagnostic markers as is imaged by MRI and or USG- a) thickened endomyometrial junctional, b) anterior posterior uterine wall asymmetry c) heterogeneous myometrial areas with irregular myometrial cystic spaces are the characteristics for diagnosis of adenomyosis. It is believed that increased peristalsis which creates increased intra uterine pressure – leads to invagination of basal endometrium into the myometrium.
Take home message 2:-
Etiology? What cause adenomyosis i.e. formation of ectopic stromal tissues /glandular/surface epithelium of endometrium to go inside the deep into myometrium? Apart from being a diagnostic parameter through USG  and MRI – JZ thickness has a great impact on inducing normal myometrial contractility which creates a favorable peristaltic movement of the myometrium for sperm and embryo transport within the uterine cavity. This coordinated movement of JZ is governed by many endocrine, neuronal & paracrine and growth factors. We know that the normal thickness of junctional zone is 7-8 mm. In adenomyosis the junctional zone thickness increases to > 12mm as it is overactive and in most cases of adenomyosis the disease is initiated from this JZ.

Take home message: 3:- Why subfertility?? 1) The myometrial peristalsis of may misdirect sperm entry into the uterine cavity which may be an independent cause of infertility in women with adenomyosis. 2) Other direct cause of infertility due to adenomyosis only is migration of macrophages into the uterine myometrium leading to production of local inflammatory exudates. 3) Release of exudates within the myometrium produces adverse utero ovarian reflex signal to the developing follicle in the ovaries resulting in liberation of poor quality oocytes.
Take home message 4:-Besides subjective symptoms of dysmenorrhea and menometrorrhagia there are four other objective signs for diagnosis of adenomyosis. These are A) laparoscopy or B) hysteroscopy with or without directed myometrial biopsyà histology. C)  Transvaginal ultrasonography and 4) MRI. TVUS and MRI are non invasive and dependable diagnostic procedures. Between the two, USG is easily available and least expensive.
Take home message 5:-In initial years association of adenomyosis with pelvic endometriosis was reported to be much less than what is being reported currently. This is because of improvement of diagnostic facilities awareness of patient population and perhaps late marriage of women.
Take home message 7: TR of adenomyosis: Some without desire for babv: Currently with adenomyosis infertility is the primary problem – conservative line of treatement is the rational approach. Medical treatment with 1)GnRH a 2)danazol or 3)aromatase inhibitors , 4) LNG-IUS and recently introduced 5) dienogest are effective but not very popular for fertility restoration
Medical TR: - Adenomyosis has a negative impact on ART outcome.
With conservative surgical treatment or with ART may produce some positive outcome.
High intensity focused ultrasound or uterine artery embolization are the alternative options with questionable outcome.
Diffuse uterine adenomyosis measuring 10 cm or more with menometrorrhagia is beyond the scope of conservative management:--Such patients require abdominal hysterectomy with preservation of ovaries for future possibility of surrogacy.
Impact of adenomyosis on obstetric outcome includes – miscarriage, ectopic pregnancy within the adenomyotic foci, preterm labor, uterine perforation, and postpartum hemorrhage.






Let see gross disparity:-


What is the conception rate and birth rate of India per day in India as was on 2018 & total no. of existing hard working dedicated competent sonologist in India capable of performing NT scan with near 100% accuracy?

Ans:-In search of certified & qualified trained dedicated Sonologists I, Dr. S K Pal at 1810 hrs of 07=-06-19 am now have arrived at the peak of the Mt. Everest peak with a lantern  in the search of  qualified and certified sonologist. . My philosophy of life is to offer quality NT scan for every Indian preg  mother.  .The idea is  to minimize D marker, Q, Marker tests & obviously NIPT expenses .. There is no disagreement globally that all preg women should  have the right to have the benefit of  having a  NT scan by right people (not by ordinary sonologist ) at right time may not be at her doorstep. , But as because all qualified and certified sonologist have disappeared, I like to catch  hold them.
Learn math before Union budget is paced by Hon’ble Finance Minister Ms Nirmala Sitharaman :-Now coming to mathematics how many babies are born each year in India and work load of such competent sonologist in India?
From GOI Bulletin we know as many as 34 births and 10 deaths are registered in India every minute. If that be so then in every day there will be new conception per day @ (34+10) x 1440( one day)  minutes = 63,360 Births per day(Term neonates+ 20% abortion rate and preterm labour ). The number goes up to 2,062 births and 603 deaths per hour, up to 49,481 births and 14,475 deaths per day and further up to 1.5 million births and 0.4 million deaths per month.